According to Fortune Business Insights, the global polymerase chain reaction (PCR) market was valued at USD 9.15 billion in 2023 and is projected to grow from USD 9.91 billion in 2024 to USD 19.23 billion by 2032, exhibiting a CAGR of 8.6% during the forecast period. In 2023, North America dominated the PCR market with a market share of 40%.
